Part of the Pharmacy and Pharmaceutical Sciences Commons

Works by S Ungureanu in Pharmacy and Pharmaceutical Sciences

2020

Difference in Control of Psychosis and Aggression for Patients Receiving the Maximum Dose of Haloperidol Decanoate Every Two Weeks Compared to Every Four Weeks, M Sherman, S Ungureanu, T Harrison, Stepan Uhlyar, Jose A. Rey
Faculty Proceedings, Presentations, Posters, Speeches, Lectures, etc.

Difference in Control of Psychosis and Aggression for Patients Receiving the Maximum Dose of Haloperidol Decanoate Every Two Weeks Compared to Every Four Weeks, M Sherman, S Ungureanu, T Harrison, Stepan Uhlyar, Jose A. Rey
Faculty Proceedings, Presentations, Posters, Speeches, Lectures, etc.

Difference in Control of Psychosis and Aggression for Patients Receiving the Maximum Dose of Haloperidol Decanoate Every Two Weeks Compared to Every Four Weeks, M Sherman, S Ungureanu, T Harrison, Stepan Uhlyar, Jose A. Rey
Faculty Proceedings, Presentations, Posters, Speeches, Lectures, etc.

Clinical Outcomes in Patients Receiving Maximum Dose Haloperidol Decanoate Every Two Weeks versus Every Four Weeks in a Long-Term Inpatient Psychiatric Facility, S Ungureanu, T Harrison, Jose A. Rey
Faculty Proceedings, Presentations, Posters, Speeches, Lectures, etc.

Adverse Drug Reactions and Metabolic Differences in Patients Receiving the Maximum Dose of Haloperidol Decanoate Every Two Weeks versus Every Four Weeks in a Long-Term Inpatient Psychiatric Facility, T Harrison, S Ungureanu, Jose A. Rey
Faculty Proceedings, Presentations, Posters, Speeches, Lectures, etc.